drugset / Trial / NCT00344058

Abbreviated MgSO4 Therapy in Post-partum Preeclampsia

NCT00344058

Completed 200 enrolled Case Western Reserve University
RandomizedParallel-groupOpen-labelTreatment

Summary

Magnesium sulfate is used for seizure prophylaxis in pregnancies complicated by preeclampsia. There is debate as to how long to continue this therapy after delivery of the pregnancy. Different schemes have been offered to shorten the exposure to magnesium sulfate after delivery, with little data. We seek to investigate the effect of shortened magnesium sulfate therapy on the post-partum recovery phase of mild preeclampsia. Our hypothesis was that shortened therapy (12 hours versus the traditional 24 hours post-partum) has no effect on disease course, and will result in significantly shorter exposure to magnesium sulfate.

Timeline

Start
2001-01
Primary completion
2004-08
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified

Indications